BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37381007)

  • 1. Incremental effect of coronary obstruction on myocardial microvascular dysfunction in type 2 diabetes mellitus patients evaluated by first-pass perfusion CMR study.
    Wang J; Yang ZG; Guo YK; Jiang Y; Yan WF; Qian WL; Fang H; Min CY; Li Y
    Cardiovasc Diabetol; 2023 Jun; 22(1):154. PubMed ID: 37381007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The additive effects of obesity on myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance first-pass perfusion study.
    Jiang L; Shi K; Guo YK; Ren Y; Li ZL; Xia CC; Li L; Liu X; Xie LJ; Gao Y; Shen MT; Deng MY; Yang ZG
    Cardiovasc Diabetol; 2020 May; 19(1):52. PubMed ID: 32375795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study.
    Liu X; Yang ZG; Gao Y; Xie LJ; Jiang L; Hu BY; Diao KY; Shi K; Xu HY; Shen MT; Ren Y; Guo YK
    Cardiovasc Diabetol; 2018 Oct; 17(1):139. PubMed ID: 30373588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.
    Li R; Yang ZG; Wen LY; Liu X; Xu HY; Zhang Q; Guo YK
    J Cardiovasc Magn Reson; 2016 Apr; 18():16. PubMed ID: 27048459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The additive effects of type 2 diabetes mellitus on left ventricular deformation and myocardial perfusion in essential hypertension: a 3.0 T cardiac magnetic resonance study.
    Li XM; Jiang L; Guo YK; Ren Y; Han PL; Peng LQ; Shi R; Yan WF; Yang ZG
    Cardiovasc Diabetol; 2020 Sep; 19(1):161. PubMed ID: 32998742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical left ventricular deformation and microvascular dysfunction in T2DM patients with and without peripheral neuropathy: assessed by 3.0 T cardiac magnetic resonance imaging.
    Li XM; Shi R; Shen MT; Yan WF; Jiang L; Min CY; Liu XJ; Guo YK; Yang ZG
    Cardiovasc Diabetol; 2023 Sep; 22(1):256. PubMed ID: 37735418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pretransplant T2DM on left ventricular deformation and myocardial perfusion in heart transplanted recipients: a 3.0 T cardiac magnetic resonance study.
    Cao L; Liu C; Ou C; Ma Q; Xu H; Li X; Bao Y; Chen R; Yang Y; Wu M; Liu H
    Cardiovasc Diabetol; 2024 Jun; 23(1):216. PubMed ID: 38907259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel implementation of cardiac magnetic resonance first-pass perfusion imaging for semi-quantitatively evaluating microvascular dysfunction in paediatric patients with Duchenne muscular dystrophy.
    Xie L; Cai X; Guo Y; Yu L; Li X; Fu C; Xu K; Song Y; Xu R; Liu H; Xu H
    Br J Radiol; 2024 Jan; 97(1153):249-257. PubMed ID: 38263818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adverse impact of coronary artery disease on left ventricle systolic and diastolic function in patients with type 2 diabetes mellitus: a 3.0T CMR study.
    Wang J; Li Y; Guo YK; Huang S; Shi R; Yan WF; Qian WL; He GX; Yang ZG
    Cardiovasc Diabetol; 2022 Feb; 21(1):30. PubMed ID: 35193565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Type 2 Diabetes Mellitus on Epicardial Adipose Tissue and Myocardial Microcirculation by MRI in Postmenopausal Women.
    Huang S; Li Y; Jiang L; Ren Y; Wang J; Shi K; Yan WF; Qian WL; Yang ZG
    J Magn Reson Imaging; 2022 Nov; 56(5):1404-1413. PubMed ID: 35179821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
    Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical cardiovascular risk calculator for asymptomatic patients with type 2 diabetes mellitus: PRECISE-DM risk score.
    Choi Y; Yang Y; Hwang BH; Lee EY; Yoon KH; Chang K; Jaffer FA; Cho JH
    Clin Cardiol; 2020 Sep; 43(9):1040-1047. PubMed ID: 32656853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The additive effect of metabolic syndrome on left ventricular impairment in patients with obstructive coronary artery disease assessed by 3.0 T cardiac magnetic resonance feature tracking.
    Min CY; Gao Y; Jiang YN; Guo YK; Shi K; Yang ZG; Li Y
    Cardiovasc Diabetol; 2024 Apr; 23(1):133. PubMed ID: 38654269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Epicardial Adipose Tissue With Left Ventricular Strain and MR Myocardial Perfusion in Patients With Known Coronary Artery Disease.
    Zhu J; Xie Z; Huang H; Li W; Zhuo K; Bai Z; Huang R
    J Magn Reson Imaging; 2023 Nov; 58(5):1490-1498. PubMed ID: 36794488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elective percutaneous coronary intervention immediately impairs resting microvascular perfusion assessed by cardiac magnetic resonance imaging.
    Taylor AJ; Al-Saadi N; Abdel-Aty H; Schulz-Menger J; Messroghli DR; Gross M; Dietz R; Friedrich MG
    Am Heart J; 2006 Apr; 151(4):891.e1-7. PubMed ID: 16569557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial first pass perfusion assessed by cardiac magnetic resonance and coronary microvascular dysfunction in women with angina and no obstructive coronary artery disease.
    Mygind ND; Pena A; Mide Michelsen M; Ali Qayyum A; Frestad D; Emil Christensen T; Ali Ghotbi A; Hasbak P; Kjaer A; Vejlstrup N; Gustafsson I; Riis Hansen P; Steen Hansen H; Prescott E; Kastrup J
    Scand J Clin Lab Invest; 2019 Jul; 79(4):238-246. PubMed ID: 30889989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of obstructive coronary artery disease in the asymptomatic high-risk population: objectives and study design of the EARLY-SYNERGY trial.
    Ties D; van Dorp P; Pundziute G; van der Aalst CM; Gratama JWC; Braam RL; Kuijpers D; Lubbers DD; van der Bilt IAC; Westenbrink BD; Wolcherink MJO; Doggen CJM; Išgum I; Nijveldt R; de Koning HJ; Vliegenthart R; Oudkerk M; van der Harst P
    Am Heart J; 2022 Apr; 246():166-177. PubMed ID: 35038412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and myocardium steatosis in subclinical type 2 diabetes mellitus: a
    Gao Y; Ren Y; Guo YK; Liu X; Xie LJ; Jiang L; Shen MT; Deng MY; Yang ZG
    Cardiovasc Diabetol; 2020 May; 19(1):70. PubMed ID: 32471503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of left ventricular myocardial involvement in patients with connective tissue disease: a 3.0T contrast-enhanced cardiovascular magnetic resonance study.
    Wang J; Gao Y; Yang ZG; Guo YK; Jiang L; Shi R; Xu HY; Huang S; Li Y
    Int J Cardiovasc Imaging; 2022 Jul; 38(7):1545-1554. PubMed ID: 35284973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired retinal microcirculation in patients with non-obstructive coronary artery disease.
    Ren Y; Hu Y; Li C; Zhong P; Liu H; Wang H; Kuang Y; Fu B; Wang Y; Zhao H; Zeng X; Kong H; Lawali DJAM; Yu D; Yu H; Yang X
    Microvasc Res; 2023 Jul; 148():104533. PubMed ID: 37004959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.